Skip to main content
profile image
Selected Works of Adam M. Kaye
Article
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.
Neurology international
  • Amber N Edinoff, Louisiana State University Health Science Center
  • Catherine A. Nix, Louisiana State University
  • Amira S. Odisho, Louisiana State University
  • Caroline P. Babin
  • Alyssa G. Derouen
  • Salim C. Lutfallah
  • Elyse M. Cornett, Louisiana State University
  • Kevin S Murnane, Louisiana State University
  • Adam M. Kaye, University of the Pacific
  • Alan David Kaye, Louisiana State University Health Science Center
Download
ORCiD
Adam M. Kaye: 0000-0002-7224-3322
Document Type
Article
DOI
10.3390/neurolint14030053
Publication Date
8-22-2022
Disciplines
Abstract

As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines. Flubromazolam(8-bromo-6-(2-fluorophenyl)-1-methyl-4

Creative Commons License
Creative Commons Attribution 4.0 International
Citation Information
Amber N Edinoff, Catherine A. Nix, Amira S. Odisho, Caroline P. Babin, et al.. "Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects." Neurology international Vol. 14 Iss. 3 (2022) p. 648 - 663 ISSN: 2035-8385
Available at: http://works.bepress.com/adam-kaye/213/